Valuation: Photocure ASA

Market Cap 1.34B 143M 127M 118M 107M 201M 13.54B 205M 1.41B 556M 7.08B 536M 525M 22.62B P/E 2026 *
17.7x
P/E 2027 * 64x
Enterprise Value 1.18B 125M 111M 103M 93.74M 176M 11.84B 179M 1.24B 486M 6.19B 468M 459M 19.78B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.78x
Free-Float
95.71%
Yield 2026 *
-
Yield 2027 * -
1 day-0.10%
1 week+1.73%
Current month-0.80%
1 month-5.49%
3 months-13.37%
6 months-33.20%
Current year-30.11%
1 week 48.9
Extreme 48.9
50.5
1 month 47.1
Extreme 47.1
53.1
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 46.25
Extreme 46.25
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/25 BuyCompany 11,355 0.0419%
4/2/25 BuyCompany 8,997 0.0332%
3/31/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%+1.73%-4.22%-8.78% 143M
+4.49%+10.87%+59.87%+121.21% 1,106B
+1.97%+4.40%+33.98%+69.64% 612B
+2.01%+5.13%+24.30%+97.25% 500B
+2.08%+7.89%+38.10%+62.43% 367B
+3.04%+4.72%+72.25%+44.82% 354B
+1.20%+5.48%+20.84%+48.40% 286B
+1.08%+5.35%-0.25%+20.15% 256B
+2.30%+5.04%+42.97%+55.54% 230B
+1.77%+5.81%+27.13%+101.18% 190B
Average +2.00%+2.01%+31.50%+61.18% 390.03B
Weighted average by Cap. +2.69%+2.30%+40.93%+80.75%

Financials

2026 *2027 *
Net sales 658M 69.93M 62.33M 57.74M 52.5M 98.52M 6.63B 100M 693M 272M 3.47B 262M 257M 11.08B 666M 70.78M 63.09M 58.44M 53.14M 99.72M 6.71B 101M 701M 276M 3.51B 266M 260M 11.21B
Net income 76.33M 8.11M 7.23M 6.7M 6.09M 11.42M 769M 11.61M 80.3M 31.58M 402M 30.42M 29.78M 1.28B 21M 2.23M 1.99M 1.84M 1.67M 3.14M 211M 3.19M 22.09M 8.69M 111M 8.37M 8.19M 353M
Net Debt -169M -17.95M -16M -14.82M -13.48M -25.29M -1.7B -25.71M -178M -69.91M -890M -67.35M -65.94M -2.84B -157M -16.68M -14.87M -13.77M -12.52M -23.49M -1.58B -23.88M -165M -64.95M -826M -62.57M -61.26M -2.64B
Projected Income Statement - Annual - Photocure ASA
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-10-20 NOK 49.90 -0.10% 15,799
26-10-19 NOK 49.95 +0.40% 30,984
26-10-16 NOK 49.75 +1.02% 29,517
26-10-15 NOK 49.25 -0.71% 23,611
26-10-14 NOK 49.60 +1.12% 21,880
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Photocure ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
49.95NOK
Average target price
79.67NOK
Spread / Average Target
+59.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Photocure ASA